Diseases Associated With Negative Regulation Of Dendritic Spine Development
Disease |
Seizures
|
Nerve Degeneration
|
Alzheimer's Disease
|
Alzheimer Disease Type 2
|
Amyloidosis
|
Arteriosclerosis
|
Arthritis, Juvenile
|
Atherosclerosis
|
Carcinoma
|
Squamous Cell Carcinoma
|
Cardiac Hypertrophy
|
Cardiovascular Disease
|
Carotid Artery Diseases
|
Carotid Stenosis
|
Cerebral Amyloid Angiopathy
|
Cognitive Impairment
|
Coronary Heart Disease
|
Drug-Induced Liver Injury
|
Drug-Related Side Effects And Adverse Reactions
|
Dyslipidemias
|
Emphysema
|
Endometriosis
|
Hearing Loss
|
Hepatolenticular Degeneration
|
Hypercholesterolemia
|
Hyperlipidemias
|
Hypercholesterolemia, Familial
|
Hyperlipoproteinemia Type Iii
|
Hypertension
|
Leukemia, Myeloid
|
Lipoprotein Glomerulopathy
|
Lung Neoplasms
|
Age-Related Macular Degeneration
|
Macular Degeneration, Age-Related, 1
|
Mammary Neoplasms, Animal
|
Mammary Neoplasms, Experimental
|
Melanoma
|
Mercury Poisoning
|
Microsatellite Instability
|
Multiple Sclerosis
|
Multiple Sclerosis, Relapsing-Remitting
|
Myocardial Infarction
|
Neurodegenerative Diseases
|
Obesity
|
Plaque, Atherosclerotic
|
Prostatic Neoplasms
|
Proteinuria
|
Psoriasis
|
Chronic Obstructive Pulmonary Disease
|
Renal Insufficiency
|
Schizophrenia
|
Sea-Blue Histiocyte Syndrome
|
Splenomegaly
|
Tuberculosis, Pulmonary
|
Abortion, Spontaneous
|
Urinary Bladder Neoplasms
|
Adenocarcinoma
|